These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32572920)

  • 1. Silence of ATAD2 inhibits proliferation of colorectal carcinoma via the Rb-E2F1 signaling.
    Wang JH; Yu TT; Li Y; Hao YP; Han L; Xu KY; Xu P
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6055-6063. PubMed ID: 32572920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of ATAD2 Inhibits Proliferation and Tumorigenicity Through the Rb-E2F1 Pathway and Serves as a Novel Prognostic Indicator in Gastric Cancer.
    Zhou X; Ji H; Ye D; Li H; Liu F; Li H; Xu J; Li Y; Xiang F
    Cancer Manag Res; 2020; 12():337-351. PubMed ID: 32021447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-200b-5p inhibits proliferation of ovarian cancer cells by targeting ATAD2 and regulating PI3K/AKT signaling pathway.
    Wang AQ; Lv M; Xu YH; Xie PM; Dong YY
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9860-9868. PubMed ID: 33090389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of ATAD2 indicates Poor Prognosis in Oral Squamous Cell Carcinoma.
    Wang XL; Wang S; Wu ZZ; Yang QC; Li H; Xiong HG; Wan SC; Sun ZJ
    Int J Med Sci; 2020; 17(11):1598-1609. PubMed ID: 32669963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATAD2 overexpression is associated with progression and prognosis in colorectal cancer.
    Hou M; Huang R; Song Y; Feng D; Jiang Y; Liu M
    Jpn J Clin Oncol; 2016 Mar; 46(3):222-7. PubMed ID: 26819280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Bioinformatics Analysis of the Clinical Value and Biological Function of ATAD2 in Hepatocellular Carcinoma.
    Meng X; Wang L; Zhu B; Zhang J; Guo S; Li Q; Zhang T; Zheng Z; Wu G; Zhao Y
    Biomed Res Int; 2020; 2020():8657468. PubMed ID: 32462022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NEAT1_2 functions as a competing endogenous RNA to regulate ATAD2 expression by sponging microRNA-106b-5p in papillary thyroid cancer.
    Sun W; Lan X; Zhang H; Wang Z; Dong W; He L; Zhang T; Zhang P; Liu J; Qin Y
    Cell Death Dis; 2018 Mar; 9(3):380. PubMed ID: 29515109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of AAA-domain-containing protein 2 restrains cancer stem cell properties in esophageal squamous cell carcinoma via blockade of the Hedgehog signaling pathway.
    Li N; Yu Y; Wang B
    Am J Physiol Cell Physiol; 2020 Jul; 319(1):C93-C104. PubMed ID: 31747529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of Proteasome 26S Subunit ATPase 2 Regulates Colorectal Cancer Cell Proliferation, Apoptosis, and Migration.
    He J; Xing J; Yang X; Zhang C; Zhang Y; Wang H; Xu X; Wang H; Cao Y; Xu H; Zhang C; Wang C; Yu E
    Chemotherapy; 2019; 64(3):146-154. PubMed ID: 31715603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.
    Zhou L; Yang C; Zhang N; Zhang X; Zhao T; Yu J
    Biomed Pharmacother; 2020 May; 125():109964. PubMed ID: 32044716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of ATPase family AAA domain-containing protein 2 inhibits migration and invasion of colorectal cancer cells.
    Hong S; Bi M; Yan Z; Sun D; Ling L; Zhao C
    Neoplasma; 2016; 63(6):846-855. PubMed ID: 27565322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene ATAD2 promotes cell proliferation, invasion and migration in cervical cancer.
    Zheng L; Li T; Zhang Y; Guo Y; Yao J; Dou L; Guo K
    Oncol Rep; 2015 May; 33(5):2337-44. PubMed ID: 25813398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of ATAD2 as a Potential Target in Hepatocellular Carcinoma.
    Ekin U; Yuzugullu H; Ozen C; Korhan P; Bagirsakci E; Yilmaz F; Yuzugullu OG; Uzuner H; Alotaibi H; Kirmizibayrak PB; Atabey N; Karakülah G; Ozturk M
    J Gastrointest Cancer; 2021 Dec; 52(4):1356-1369. PubMed ID: 34738187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATAD2 drives colorectal cancer progression by regulating TRIM25 expression via a positive feedback loop with E2F transcriptional factors.
    Tong Y; Li J; Peng M; Qian Q; Shi W; Chen Z; Liu B
    Biochem Biophys Res Commun; 2022 Feb; 594():146-152. PubMed ID: 35085891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling.
    Fang Z; Gong C; Yu S; Zhou W; Hassan W; Li H; Wang X; Hu Y; Gu K; Chen X; Hong B; Bao Y; Chen X; Zhang X; Liu H
    Cancer Lett; 2018 Feb; 415():58-72. PubMed ID: 29203250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin receptor substrate-4 is overexpressed in colorectal cancer and promotes retinoblastoma-cyclin-dependent kinase activation.
    Sanmartín-Salinas P; Lobo MDVT; Noguerales-Fraguas F; Londoño MT; Jiménez-Ruiz A; Guijarro LG
    J Gastroenterol; 2018 Aug; 53(8):932-944. PubMed ID: 29353348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of microRNA-186 inhibits angiogenesis in retinoblastoma via the Hedgehog signaling pathway by targeting ATAD2.
    Wu S; Han M; Zhang C
    J Cell Physiol; 2019 Aug; 234(10):19059-19072. PubMed ID: 30993715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation.
    Liu Q; Liu H; Li L; Dong X; Ru X; Fan X; Wen T; Liu J
    Int J Oncol; 2020 Jan; 56(1):219-231. PubMed ID: 31746426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma.
    Ge T; Liu T; Guo L; Chen Z; Lou G
    Exp Cell Res; 2020 Nov; 396(1):112241. PubMed ID: 32835657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATAD2 expression increases [18F]Fluorodeoxyglucose uptake value in lung adenocarcinoma via AKT-GLUT1/HK2 pathway.
    Sun T; Du B; Diao Y; Li X; Chen S; Li Y
    BMB Rep; 2019 Jul; 52(7):457-462. PubMed ID: 31186081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.